Kolumne, ORE

Original-Research: INDUS Holding AG - from NuWays AG Classification of NuWays AG to INDUS Holding AG Company Name: INDUS Holding AG ISIN: DE0006200108 Reason for the research: Update Recommendation: BUY from: 22.02.2024 Target price: 36.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid FY23 prelims / / focus on strong FCF & share buyback; chg.

22.02.2024 - 09:01:32

Original-Research: INDUS Holding AG (von NuWays AG): BUY


Original-Research: INDUS Holding AG - from NuWays AG

Classification of NuWays AG to INDUS Holding AG

Company Name: INDUS Holding AG
ISIN: DE0006200108

Reason for the research: Update
Recommendation: BUY
from: 22.02.2024
Target price: 36.00
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Christian Sandherr

Solid FY23 prelims // focus on strong FCF & share buyback; chg.
 
Topic: While prelim. FY23 sales and EBIT came in largely as expected, the
strong FCF generation of EUR 190m is well above expectations. On top, INDUS
announced a 4.1% share buyback at EUR 23.
 
Preliminary FY23 sales remained stable yoy at EUR 1.80bn (eNuW: EUR 1.82bn),
despite unfavourable economic conditions in the construction industry; Q4
sales -5.0% yoy to EUR 436m. Thanks to a strong Engineering Segment, FY23
operating EBIT came in at EUR 150m (eNuW: EUR 152m), implying a 8.3% margin, up
0.9pp yoy and above the guidance range of 7-8%; Q4 EBIT of EUR 32.7m, a 7.5%
margin.
 
The Engineering segment delivered slight revenue growth and noticeable
growth in earnings for FY23e. Sales in the Infrastructure segment were
flattish yoy with a slightly lower EBIT as the slowdown in the construction
sector impacted several portfolio companies, particularly in H1. Revenues
in the Materials segment decreased modestly but with a significantly higher
EBIT due to price increases.
 
Most importantly, Free cashflow came in above EUR 190m materially improving
yoy (2022: EUR 102m), exceeding the guidance of EUR 100m and eNuW of EUR 89m,
caused by further noticeable working capital normalizations. As a result,
net debt decreased by EUR 87.3m to EUR 506m, strengthened the equity ratio to
37.3% (FY22: 36.8%). Further, the strong cashflow generation gives INDUS
with additional financial flexibility regarding acquisitions and dividend
payments.
 
Thanks to the INDUS announced a share buyback for up to 1.1m shares at a
price of EUR 23 during the period from February 22nd, 2024 to March 1st,
2024. Thus, the volume of the buyback amounts up to EUR 25.3m in aggregate,
leading to approximately 4.09% of the company's registered share capital.
This underlines not only the strong cash generation of the company but also
the current undervaluation.
 
FY24e guidance in line with expectations. Management anticipates revenues
in the range of EUR 1.85-1.95bn (eNuW: EUR 1.88bn) with an EBIT between EUR
145-165m in FY24e (eNuW: EUR 150m). Despite of the continuously challenging
end markets and general macroeconomic conditions, we regard the guidance as
doable due to price increases and slight pickup of demand across several
portfolio companies.
 
Trading at only 4.1x EV/EBITDA 2023e, 59% below its historical average,
INDUS remains attractively priced. We reiterate our BUY rating with an
increased PT of EUR 36 (old: EUR 34) based on FCFY 2024e.

You can download the research here:
http://www.more-ir.de/d/28957.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...